Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing
Larsson, A.
Lakartidningen 103(19) 1537; Discussion: 1537-1538
2006
ISSN/ISBN: 0023-7205 PMID: 16805251 Document Number: 602626
Document emailed within 1 workday
Related Documents
Ellis, J.M. 2005: Cholinesterase inhibitors in the treatment of dementia Journal of the American Osteopathic Association 105(3): 145-158Vasenina, E.E. 2013: Cholinesterase inhibitors in the treatment of mixed dementia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7 Part 2): 98-103
Rösler, M. 2002: The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia International Journal of Clinical Practice. Suppl 127: 20-36
Richard, E.; van Gool, W.A. 2006: Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety Nederlands Tijdschrift Voor Geneeskunde 150(10): 530-532
Krüger, R.; Weiss, D. 2011: Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease MMW Fortschritte der Medizin 153(14): 29-32; Quiz 33
Shinotoh, H. 1999: Dementia with Lewy bodies and Parkinson's disease with dementia Rinsho Shinkeigaku 39(11): 1171-1172
Hitzeman, N. 2006: Cholinesterase inhibitors for Alzheimer's disease American Family Physician 74(5): 747-749
Petroianu, G.A.; Moshnin, W. 2008: The history of cholinesterase inhibitors: who was Moschnin(e)? Die Pharmazie 63(4): 325-327
Borchert, K.; Pietsch, P.; Busch, H. 1972: Use of cholinesterase inhibitors in postoperative care Zentralblatt für Chirurgie 97(4): 111-116
Ikonomoff, S.I. 1973: Effect of cholinesterase inhibitors in hysteric stupor Münchener Medizinische Wochenschrift 115(16): 701-703
Tonkopiĭ, V.D. 1975: Mechanism of the hypothermic action of reversible cholinesterase inhibitors Farmakologiia i Toksikologiia 38(2): 141-144
Takeda, A. 2011: Parkinson's disease with dementia (PDD) Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 10 Pt 2: 350-355
Moerkens, R.M.; Dhondt, A.D.F. 2003: Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine Nederlands Tijdschrift Voor Geneeskunde 147(14): 679; Author Reply 679
Sinforiani, E.; Banchieri, L.M.; Zucchella, C.; Bernasconi, L.; Nappi, G. 2003: Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population Functional Neurology 18(4): 233-237
Graipaspong, N.; Thaipisuttikul, P.; Vallipakorn, S.A.-O. 2016: Cholinesterase Inhibitors and Behavioral and Psychological Symptoms of Alzheimer's Disease Journal of the Medical Association of Thailand 99(4): 433-440
Natoff, I.L. 1970: Influence of the route of exposure on the acute toxicity of cholinesterase inhibitors Arhiv Za Higijenu Rada i Toksikologiju 21(4): 347-352
Zhang, S.S.; Ji, Q.E. 1987: Synthesis of 5-(1,3,3-trisubstituted) indolinyl-N,N-dimethylcarbamates as reversible cholinesterase inhibitors Yao Xue Xue Bao 22(2): 107-113
Gindilis, A.L.; Kurochkin, I.N. 1998: Potentiometric electrodes for determining choline, butyrylcholine and cholinesterase inhibitors Prikladnaia Biokhimiia i Mikrobiologiia 34(3): 326-331
Balashova, E.K.; Pevzner, D.L.; Rozengart, V.I.; Sherstobitov, O.E. 1974: Determination of hydrophobic organic phosphorus cholinesterase inhibitors in the blood Laboratornoe Delo 12: 719-720
Williamson, A.M.; Sarvey, J.M. 1985: Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus Journal of Pharmacology and Experimental Therapeutics 235(2): 448-455